https://www.biospace.com/myriad-genetics-to-announce-quarterly-financial-results-on-november-9-2020
Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostics and precision medicine, announced that it will hold its quarterly earnings conference...
myriad geneticsannouncequarterlyfinancialresults
https://www.macrotrends.net/stocks/charts/MYGN/myriad-genetics/shares-outstanding
Myriad Genetics shares outstanding from 2012 to 2025. Shares outstanding can be defined as the number of shares held by shareholders (including insiders)...
myriad geneticsshares outstandingmygn
https://www.macrotrends.net/stocks/charts/MYGN/myriad-genetics/roi
Current and historical return on investment (ROI) values for Myriad Genetics (MYGN) over the last 10 years.
return on investmentmyriad geneticsmygn